AIM To perform a systematic review and meta-analysis on proton pump inhibitors (PPIs)
therapy and the risk of Clostridium difficile infection (CDI). METHODS We conducted a …

Background. Fecal microbiota transplantation (FMT) has been shown to be effective in
recurrent Clostridium difficile (CD) infection, with resolution in 80% to 90% of patients …

Although major advances in the care of cancer patients over the past several decades have
resulted in improved survival, infectious complications remain a significant cause of …

The scientific literature has demonstrated that glutamine is one of the main beneficial amino
acids. It plays an important role in gut microbiota and immunity. This paper provides a critical …

Background and aims Pancreatic ductal adenocarcinoma (PDAC) represents the fourth
cause of cancer-related death. We aimed to evaluate whether gemcitabine treatment shapes …

We present a case of severe C lostridium difficile infection (CDI) in a non‐neutropenic
allogeneic hematopoietic stem cell transplant recipient who was treated successfully with …

Clostridium difficile infection (CDI) presents a rapidly evolving challenge in the battle against
hospital-acquired infections. Recent advances in CDI diagnosis and management include …

Clostridium difficile infection (CDI) is an emerging problem worldwide associated with
significant morbidity, mortality, recurrence rates and healthcare costs. Immunosuppressed …

Aim It is unclear whether colectomy for fulminant Clostridium difficile colitis (FCDC) leads to
a improvement in survival compared with continued medical therapy for this moribund …

Clostridium difficile has become the most common bacterial cause of nosocomial diarrhea.
High rates of C. difficile infection (CDI) coupled with increasing morbidity and mortality …